Anticoagulation Market 2022 | Present Scenario and Growth Prospects 2027: MRFR

 

Anticoagulation Market Overview

The Anticoagulation Market is projected to reach USD 31,696.59 million by 2027 at a CAGR of 7.80% during the forecast period. The global Anticoagulation Market is growing steadily due to the rising demand for anticoagulants, which creates lucrative growth opportunities for the number of players coming forward with new and better products. The value chain analysis of the market comprises four major components: research & development and designing, manufacturing the products, distribution & sales, and post-sales services.

Research &development start with conceptualizing, followed by design, then development, and lastly, testing. The R&D segment comprises 25-30% of the value chain. After the product designs are final, the manufacturing of the product starts. Manufacturing consists of 45-50% of the value chain. Then comes distribution and sales, which is essential for any industry

Market Segmentation

The global anticoagulation market is segmented into drug class, route of administration, disease indication, distribution channel, and region. The drug class segment has been further segmented into direct oral anticoagulants (DOACs), warfarin,vitamin K,and heparins&Low Molecular Weight Heparin (LMWH). The disease indication segment is further segmented into heart attacks,stroke, Deep Vein Thrombosis (DVT)/Pulmonary Embolism (PE), Mechanical Heart Valves (MHV), and others. The route of administration segment has been further segmented into oral, injectable, andothers.The distribution channel segment is segmented into retail pharmacies,hospital pharmacies, andonline pharmacies.

Regional Analysis

The global anticoagulation market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World.

The North American market accounted for the largest share in 2019 and is expected to increase at a CAGR of 8.20% during the forecast period. This is due to the rising prevalence of venous thromboembolism (VTE) and cardiovascular disorders, increased risk of a blood clot in various medical conditions, and the adoption of NOACs globally. According to a published article in PubMed in 2019, NOACs have emerged as promising alternatives to Vitamin K Antagonists (VKAs). However, there are some considerations and challenges to their introduction in developing countries.

Europe accounted for a market size of USD 5,205.37million in 2019 and is expected to grow at a CAGR of 7.26% during the forecast period. It has evolved as a prominent market with increased cardiovascular diseases and rising investments in R&D in the pharmaceutical sector. The region has considerable growth potentials that would help expand the global market in the coming years. However, stringent regulations set by various governments are hampering the market growth in the European region.

The anticoagulation market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. Asia-Pacific is expected to showthe highest growth rate during the forecast period from 2020 to 2027. Factors such as an increasing patient population suffering from various chronic and acute diseases, rising prevalence of cardiovascular disease and VTE, developing economies, improving diagnosis rate, and growing demand for ideal therapeutics are anticipated to boost the market growth. Furthermore, continuous economic development with evolving healthcare infrastructure and improving healthcare awareness have further supported the market's growth. However, increasing treatment expenditure for anticoagulant drugs is anticipated to hamper the market growth in the Asia-Pacific region.

The Rest of the World is segmented into the Middle East, Africa, and Latin America. The Middle East & Africa region market is expected to witness significant growth due to the increasing number of research companies and subsidiaries involved in R&D activities for anticoagulants. The rising prevalence of cardiovascular disorders in the region is also influencing the growth of the anticoagulation market.

Key Players

Anticoagulation Market Players are Pfizer Inc (US), Sanofi (France), Novartis AG (Switzerland), GlaxoSmithKline plc (UK), Daiichi Sankyo Company, Limited, Inc. (Japan), Johnson & Johnson Services Inc (US), Boehringer Ingelheim International GmbH (Germany), Bristol-Myers Squibb Company (US), F. Hoffmann-La Roche Ltd (Switzerland), and Portola Pharmaceuticals, Inc (US).

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

 

 


Comments

Post a Comment

Popular posts from this blog

Medical Device Reprocessing Market Development Strategy, Future Plans, Competitive Landscape And Regional Forecast To 2030

Image
  Medical Device Reprocessing Market Overview The global medical device reprocessing market is expected to exhibit a strong 15.7% CAGR over the forecast period from 2022 to 2030, according to the latest research report from Market Research Future (MRFR). The report presents a detailed overview of the global medical device reprocessing market, including an overview of the market’s historical progress and projections about the market’s future growth over the forecast period from 2022 to 2030. The competitive landscape of the market is also assessed in detail in the report, including company profiles of the leading players operating in the market and an analysis of the competitive strategies employed by the major players in the market. The segmentation of the market is also profiled in the report to provide an analysis of the major parts of the market. Readers are given clear indications as to the most profitable areas of the market over the forecast period. Medical device reproce...
Read more

Medical Document Management Systems Market Key Players, Competitive Landscape, Growth, Statistics, Revenue and Industry Analysis Report by 2030

Image
  Medical Document Management Systems Market Overview Medical document management systems have become a necessity due to the vast amounts of patient data which is being generated on a regular basis. Market Research Future has analyzed the global medical document management system market with great scrutiny, and the findings published in its report suggest considerable growth during the upcoming forecast period. The medical document management systems market is expected to reach USD 2.8 billion by 2030 at 10.8% CAGR during the forecast period 2022-2030 A primary driver of the global Medical Document Management Systems Market is the tremendous daily volume of information generated by medical end-users. Medical document management systems offer consolidation of all data in one place for easy data retrieval. Ongoing treatments and patient history can be easily accessed via the use of medical document management systems, thus driving growth for the market. Updation of files in...
Read more

Nanobody Market Forecast Size, Share, Growth, Latest Trends, Global Forecast 2030

Image
  Nanobody Market Overview According to MRFR analysis, the global nanobody market is expected to register a CAGR of 24.2% from 2022 to 2030 and hold a value of over USD 1.14 billion by 2030. The global market of nanobody is driven by various factors, such as rising healthcare expenditure and increasing investments in R&D activities to develop nanobody-based therapeutics. In addition, the growing usage of nanobodies in various applications such as in vivo imaging, antivenom therapy, and immune-based therapeutics among others is also driving the market growth of the nanobody. Moreover, the progress of various nanobody products in clinical trials and their subsequent approval further boost the growth of the market. Furthermore, rising health-related concerns coupled with favorable reimbursement policies for availing healthcare services are anticipated to fuel the growth of the nanobody market during the forecast period. Nanobody Market Segmentation The global nanobod...
Read more